® [1] HAMILTON, BERMUDA / ACCESS Newswire / December 19, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and supplying nucleic acid delivery technology for partners in biotech and pharma, today announced that its associate company Altamira Medica ("Medica") has obtained marketing approval from the National Medical Products Administration (NMPA) of China for its Bentrio nasal spray in allergic rhinitis. The clearance will allow Nuance Pharma, M ...